肾细胞癌流行病学:2022年更新
本文通过系统综述Medline和Scopus文献,总结全球肾癌发病率与死亡率的地域、性别和时间差异,并分析肥胖、高血压、吸烟等已确立的危险因素及家族综合征和遗传改变等生物学危险因素。
要点
- 肾癌发病率持续上升,但死亡率模型已趋于平稳。
- 高血压、肥胖和吸烟是最明确的肾癌危险因素。
- 目前可避免的主要病因是吸烟、肥胖和高血压。
核心结论
- 肾癌发病率和死亡率随地理、性别和年龄显著变化。
- 肥胖、高血压、吸烟和慢性肾脏病(CKD)/终末期肾病(ESKD)与肾癌发生的关联已被充分描述。
- 遗传学进展有助于识别易感生殖系和体细胞突变,并可能发现改善高危患者结局的治疗靶点。
研究设计与样本
- 通过Medline(PubMed)和Scopus进行系统综述,纳入关于肾细胞癌、流行病学和危险因素的Meta分析、综述和原始研究。
- 采用叙述性综述形式分析肾癌发病率和死亡率。
主要发现
- 肾癌发病率持续增加,而死亡率模型已趋于平稳。
- 发病率和死亡率随时间、地理和性别存在显著差异。
- 高血压、肥胖和吸烟是最明确的危险因素。
- 新的遗传数据与观察数据结合,有助于肾癌管理的整合监测策略。
临床怎么用
- 目前可避免的主要病因是吸烟、肥胖和高血压。
- 预防和治疗吸烟、肥胖和高血压这三项因素为降低肾癌风险提供了最佳机会。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: International variations in the rates of kidney cancer (KC) are considerable. An understanding of the risk factors for KC development is necessary to generate opportunities to reduce its incidence through prevention and surveillance. OBJECTIVE: To retrieve and summarize global incidence and mortality rates of KC and risk factors associated with its development, and to describe known familial syndromes and genetic alterations that represent biologic risk factors. EVIDENCE ACQUISITION: A systematic review was conducted via Medline (PubMed) and Scopus to include meta-analyses, reviews, and original studies regarding renal cell carcinoma, epidemiology, and risk factors. EVIDENCE SYNTHESIS: Our narrative review provides a detailed analysis of KC incidence and mortality, with significant variations across time, geography, and sex. In particular, while KC incidence has continued to increase, mortality models have leveled off. Among the many risk factors, hypertension, obesity, and smoking are the most well established. The emergence of new genetic data coupled with observational data allows for integrated management and surveillance strategies for KC care. CONCLUSIONS: KC incidence and mortality rates vary significantly by geography, sex, and age. Associations of the development of KC with modifiable and fixed risk factors such as obesity, hypertension, smoking, and chronic kidney disease (CKD)/end-stage kidney disease (ESKD) are well described. Recent advances in the genetic characterization of these cancers have led to a better understanding of the germline and somatic mutations that predispose patients to KC development, with potential for identification of therapeutic targets that may improve outcomes for these at-risk patients. PATIENT SUMMARY: We reviewed evidence on the occurrence of kidney cancer (KC) around the world. Currently, the main avoidable causes are smoking, obesity, and high blood pressure. Although other risk factors also contribute, prevention and treatment of these three factors provide the best opportunities to reduce the risk of developing KC at present.
引用
- Bukavina L, Bensalah K, Bray F, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022. PMID: 36100483. doi:10.1016/j.eururo.2022.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。